• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血清乳酸水平的列线图在预测2型糖尿病患者糖尿病肾病中的应用

Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.

作者信息

Jiang Chunxia, Ma Xiumei, Chen Jiao, Zeng Yan, Guo Man, Tan Xiaozhen, Wang Yuping, Wang Peng, Yan Pijun, Lei Yi, Long Yang, Law Betty Yuen Kwan, Xu Yong

机构信息

Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macao, People's Republic of China.

Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2024 Mar 1;17:1051-1068. doi: 10.2147/DMSO.S453543. eCollection 2024.

DOI:10.2147/DMSO.S453543
PMID:38445169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10913800/
Abstract

PURPOSE

To establish nomograms integrating serum lactate levels and traditional risk factors for predicting diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) patients.

PATIENTS AND METHODS

A total of 570 T2DM patients and 100 healthy subjects were enrolled. T2DM patients were categorized into normal and high lactate groups. Univariate and multivariate logistic regression analyses were employed to identify independent predictors for DKD. Then, nomograms for predicting DKD were established, and the model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis (DCA).

RESULTS

T2DM patients exhibited higher lactate levels compared to those in healthy subjects. Glucose, platelet, uric acid, creatinine, and hypertension were independent factors for DKD in T2DM patients with normal lactate levels, while diabetes duration, creatinine, total cholesterol, and hypertension were indicators in high lactate levels group (<0.05). The AUC values were 0.834 (95% CI, 0.776 to 0.891) and 0.741 (95% CI, 0.688 to 0.795) for nomograms in both normal lactate and high lactate groups, respectively. The calibration curve demonstrated excellent agreement of fit. Furthermore, the DCA revealed that the threshold probability and highest Net Yield were 17-99% and 0.36, and 24-99% and 0.24 for the models in normal lactate and high lactate groups, respectively.

CONCLUSION

The serum lactate level-based nomogram models, combined with traditional risk factors, offer an effective tool for predicting DKD probability in T2DM patients. This approach holds promise for early risk assessment and tailored intervention strategies.

摘要

目的

建立整合血清乳酸水平和传统危险因素的列线图,用于预测2型糖尿病(T2DM)患者的糖尿病肾病(DKD)。

患者与方法

共纳入570例T2DM患者和100例健康受试者。T2DM患者分为正常乳酸组和高乳酸组。采用单因素和多因素logistic回归分析确定DKD的独立预测因素。然后,建立预测DKD的列线图,并使用受试者操作特征曲线下面积(AUC)、校准和决策曲线分析(DCA)评估模型性能。

结果

与健康受试者相比,T2DM患者的乳酸水平更高。在乳酸水平正常的T2DM患者中,血糖、血小板、尿酸、肌酐和高血压是DKD的独立因素,而糖尿病病程、肌酐、总胆固醇和高血压是高乳酸水平组的指标(P<0.05)。正常乳酸组和高乳酸组列线图的AUC值分别为0.834(95%CI,0.776至0.891)和0.741(95%CI,0.688至0.795)。校准曲线显示拟合度极佳。此外,DCA显示,正常乳酸组和高乳酸组模型的阈值概率和最高净收益分别为17 - 99%和0.36,以及24 - 99%和0.24。

结论

基于血清乳酸水平的列线图模型结合传统危险因素,为预测T2DM患者的DKD概率提供了一种有效工具。这种方法有望用于早期风险评估和制定个性化干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/f6a344312594/DMSO-17-1051-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/257bfc118800/DMSO-17-1051-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/23549a40f0bd/DMSO-17-1051-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/80756034f21d/DMSO-17-1051-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/f6a344312594/DMSO-17-1051-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/257bfc118800/DMSO-17-1051-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/23549a40f0bd/DMSO-17-1051-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/80756034f21d/DMSO-17-1051-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6479/10913800/f6a344312594/DMSO-17-1051-g0004.jpg

相似文献

1
Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.基于血清乳酸水平的列线图在预测2型糖尿病患者糖尿病肾病中的应用
Diabetes Metab Syndr Obes. 2024 Mar 1;17:1051-1068. doi: 10.2147/DMSO.S453543. eCollection 2024.
2
Development and validation of a novel nomogram to predict diabetic kidney disease in patients with type 2 diabetic mellitus and proteinuric kidney disease.开发和验证一种新的列线图模型以预测 2 型糖尿病合并蛋白尿性肾病患者的糖尿病肾脏疾病。
Int Urol Nephrol. 2023 Jan;55(1):191-200. doi: 10.1007/s11255-022-03299-x. Epub 2022 Jul 23.
3
[Blood Lipid Indicators and Different Clinical Classifications of Dyslipidemia and Diabetic Kidney Disease: Correlation and Predictive Value].[血脂指标与血脂异常及糖尿病肾病的不同临床分类:相关性及预测价值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Sep;54(5):1013-1018. doi: 10.12182/20230960103.
4
Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus.开发用于估计 2 型糖尿病患者糖尿病肾病风险的筛查工具。
Technol Health Care. 2024;32(3):1807-1818. doi: 10.3233/THC-230811.
5
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.基于列线图的2型糖尿病患者糖尿病肾病风险预测模型的构建
Diabetes Metab Syndr Obes. 2024 Jan 12;17:215-225. doi: 10.2147/DMSO.S442925. eCollection 2024.
6
Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus.列线图预测 2 型糖尿病患者发生糖尿病足的风险。
Front Endocrinol (Lausanne). 2022 Jul 13;13:890057. doi: 10.3389/fendo.2022.890057. eCollection 2022.
7
Serum Uric Acid is a Better Indicator of Kidney Impairment Than Serum Uric Acid-to-Creatinine Ratio and Serum Uric Acid-to-High-Density Lipoprotein Ratio: A Cross-Sectional Study of Type 2 Diabetes Mellitus Patients.血清尿酸比血清尿酸与肌酐比值及血清尿酸与高密度脂蛋白比值更能反映肾脏损伤:一项2型糖尿病患者的横断面研究
Diabetes Metab Syndr Obes. 2023 Sep 5;16:2695-2703. doi: 10.2147/DMSO.S425511. eCollection 2023.
8
Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: A retrospective study.预测 2 型糖尿病患者糖尿病视网膜病变的列线图:一项回顾性研究。
J Diabetes Complications. 2022 Nov;36(11):108313. doi: 10.1016/j.jdiacomp.2022.108313. Epub 2022 Sep 21.
9
Predictive nomogram model for major adverse kidney events within 30 days in sepsis patients with type 2 diabetes mellitus.预测脓毒症合并 2 型糖尿病患者 30 天内主要不良肾脏事件的列线图模型。
Front Endocrinol (Lausanne). 2022 Dec 16;13:1024500. doi: 10.3389/fendo.2022.1024500. eCollection 2022.
10
Nomogram to predict the risk of acute kidney injury in patients with diabetic ketoacidosis: an analysis of the MIMIC-III database.预测糖尿病酮症酸中毒患者急性肾损伤风险的列线图:对 MIMIC-III 数据库的分析。
BMC Endocr Disord. 2021 Mar 4;21(1):37. doi: 10.1186/s12902-021-00696-8.

引用本文的文献

1
Lactate and lactylation in the kidneys: Current advances and prospects (Review).肾脏中的乳酸与乳酸化:当前进展与展望(综述)
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5562. Epub 2025 Jun 6.
2
Mechanisms for Regulatory Effects of Exercise on Metabolic Diseases from the Lactate-Lactylation Perspective.从乳酸乳酰化角度看运动对代谢性疾病调节作用的机制
Int J Mol Sci. 2025 Apr 8;26(8):3469. doi: 10.3390/ijms26083469.

本文引用的文献

1
Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review.作为糖尿病肾病生物标志物的代谢物及其相互关联途径的最新进展:一项系统综述。
Transl Res. 2024 Mar;265:71-87. doi: 10.1016/j.trsl.2023.11.002. Epub 2023 Nov 10.
2
Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy.异常的乳酸代谢与糖尿病肾病中的白蛋白尿和肾脏损伤有关。
Kidney Int. 2023 Dec;104(6):1135-1149. doi: 10.1016/j.kint.2023.08.006. Epub 2023 Oct 16.
3
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.
尿肌醇作为糖尿病肾病的一种新型预后生物标志物:一项使用核磁共振的靶向代谢组学研究
Kidney Res Clin Pract. 2023 Jul;42(4):445-459. doi: 10.23876/j.krcp.22.152. Epub 2023 Jul 25.
4
Associations of lactate dehydrogenase with risk of renal outcomes and cardiovascular mortality in individuals with diabetic kidney disease.乳酸脱氢酶与糖尿病肾病患者的肾脏结局和心血管死亡率风险的相关性。
Diabetes Res Clin Pract. 2023 Sep;203:110838. doi: 10.1016/j.diabres.2023.110838. Epub 2023 Jul 20.
5
Accumulation of Renal Fibrosis in Hyperuricemia Rats Is Attributed to the Recruitment of Mast Cells, Activation of the TGF-β1/Smad2/3 Pathway, and Aggravation of Oxidative Stress.高尿酸血症大鼠肾纤维化的积累归因于肥大细胞的募集、TGF-β1/Smad2/3 通路的激活以及氧化应激的加重。
Int J Mol Sci. 2023 Jun 29;24(13):10839. doi: 10.3390/ijms241310839.
6
A Multifactorial Risk Score System for the Prediction of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.用于预测2型糖尿病患者糖尿病肾病的多因素风险评分系统
Diabetes Metab Syndr Obes. 2023 Feb 10;16:385-395. doi: 10.2147/DMSO.S391781. eCollection 2023.
7
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional data.中国2型糖尿病微血管并发症可改变危险因素的人群归因分数:基于全国横断面数据的分析
Diabetes Obes Metab. 2023 Apr;25 Suppl 1:5-12. doi: 10.1111/dom.15029. Epub 2023 Mar 8.
8
Lactate dehydrogenase is associated with flow-mediated dilation in hypertensive patients.乳酸脱氢酶与高血压患者的血流介导扩张有关。
Sci Rep. 2023 Jan 14;13(1):768. doi: 10.1038/s41598-023-27614-3.
9
Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.含喹唑啉-4(3H)-酮环的新型乙酸衍生物:强效醛糖还原酶抑制剂的合成、体外及计算机模拟评价
Drug Dev Res. 2023 Apr;84(2):275-295. doi: 10.1002/ddr.22031. Epub 2023 Jan 4.
10
Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes.2 型糖尿病患者中糖尿病病程较长者发生慢性肾脏病的危险因素。
Front Endocrinol (Lausanne). 2022 Dec 9;13:1079725. doi: 10.3389/fendo.2022.1079725. eCollection 2022.